Biosimilars & Generics in the Pre-Emerging and Emerging Markets
02.08.2013 17:13
You work in the field of branded generics, biosimilars or the so called generic plus products? Then this seminar will help you to identify new and upcoming markets outside the EU.
Termindetails
Wann
06.12.2013
von 09:00 bis 17:00
von 09:00 bis 17:00
Wo
Frankfurt
Kontakttelefon
06221 500 680
Teilnehmer
This seminar addresses the needs of those
working in the generics and biosimilar
industry. Especialls managing directors and
managers from the following divisions will benefit from this course:
- R & D and regulatory affairs
- business development
- market access & sales
working in the generics and biosimilar
industry. Especialls managing directors and
managers from the following divisions will benefit from this course:
- R & D and regulatory affairs
- business development
- market access & sales
You will learn about the global regulatory framework for biosimilars in the various countries and why you don't always need to be the first on the market. You'll also get to know the opportunities still available for branded generics outside the EU now and in the near future.
After having completed this seminar you will have a set of concrete ideas on how you could further improve your business development globally.
Topics:
- Risks and rewards of being late with biosimilars
- China - a market for European generic plus products
- How European companies can better penetrate LATAM
- Using branded generics for expansion into emerging markets
- The biosimilar global regulatory environment
